Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2017

04.09.2017 | Original Article

A Prospective Evaluation of Ileocecal Valve Dysfunction and Intestinal Motility Derangements in Small Intestinal Bacterial Overgrowth

verfasst von: Bani Chander Roland, Gerard E. Mullin, Monica Passi, Xi Zheng, Ahmed Salem, Robert Yolken, Pankaj Jay Pasricha

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Small intestinal bacterial overgrowth (SIBO) is an increasingly recognized clinical syndrome; however, its etiophathogenesis is poorly understood. We hypothesized that loss of gastric acid, a delayed intestinal transit, and ileocecal valve dysfunction may contribute to the genesis of this syndrome.

Aims

Our primary aim was to assess these parameters using wireless motility capsule (WMC) testing and to correlate them with the presence or absence of SIBO.

Methods

We prospectively evaluated 30 consecutive patients at a tertiary care center with suspected SIBO, diagnosed by lactulose hydrogen breath testing (LBT), and small bowel aspirate microbiology. Patients underwent WMC testing to assess ileocecal junction pressure (ICJP), small bowel transit time (SBTT), and regional gastrointestinal pH.

Results

Thirty patients completed testing; 15 had a positive LBT, and 11 had a positive aspirate culture. As compared with LBT-negative patients, ICJP was lower (27.8 vs. 72.7 mmHg, p = 0.027), SBTT was longer (10.0 vs. 1.1 h, p = 0.004), gastric pH was higher (3.63 vs. 2.42, p < 0.01), and small bowel pH was higher (6.96 vs. 6.61, p = 0.05). A hypotensive ICJP (<46.61 mmHg) was more prevalent in LBT-positive patients as compared with LBT-negative patients (73.3 vs. 14.29%, p = 0.003). Logistic regression models were used to assess the magnitude of each measured WMC parameter and the presence of SIBO. p values ≤0.05 were considered statistically significant.

Conclusions

Patients with SIBO have significantly lower ICJP, prolonged SBTT, and a higher gastrointestinal pH as compared to those without SIBO. These abnormalities may play different roles in the pathogenesis of SIBO, facilitating more targeted treatment to prevent recurrences of SIBO.
Literatur
1.
Zurück zum Zitat Vantrappen G, Janssens J, Hellemans J, et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158–1166.CrossRefPubMedPubMedCentral Vantrappen G, Janssens J, Hellemans J, et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158–1166.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31:875–880.CrossRefPubMed Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31:875–880.CrossRefPubMed
3.
Zurück zum Zitat Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461–1467.CrossRefPubMed Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461–1467.CrossRefPubMed
4.
Zurück zum Zitat Pimentel M, Park S, Mirocha J, et al. The effect of a non-absorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557–563.CrossRefPubMed Pimentel M, Park S, Mirocha J, et al. The effect of a non-absorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145:557–563.CrossRefPubMed
5.
6.
Zurück zum Zitat Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth, a comprehensive review. Gastroenterol Hepatol (N Y). 2007;3:112–122. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth, a comprehensive review. Gastroenterol Hepatol (N Y). 2007;3:112–122.
7.
Zurück zum Zitat Abu-Shanab A, Quigley EMM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist. Expert Rev. Gastroenterol Hepatol. 2009;3:77–87. Abu-Shanab A, Quigley EMM. Diagnosis of small intestinal bacterial overgrowth: the challenges persist. Expert Rev. Gastroenterol Hepatol. 2009;3:77–87.
8.
Zurück zum Zitat Quera PR, Quigley EM, Madrid S. Small intestinal bacterial overgrowth. An update. Rev Med Chil. 2005;133:1361–1370.CrossRef Quera PR, Quigley EM, Madrid S. Small intestinal bacterial overgrowth. An update. Rev Med Chil. 2005;133:1361–1370.CrossRef
9.
Zurück zum Zitat Quigley EM, Borody TJ, Phillips SF, et al. Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology. 1984;87:857–866.PubMed Quigley EM, Borody TJ, Phillips SF, et al. Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology. 1984;87:857–866.PubMed
10.
Zurück zum Zitat Miller LS, Vegesna AK, Sampath AM. Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study. World J Gastroenterol. 2012;18:6801–6808.CrossRefPubMedPubMedCentral Miller LS, Vegesna AK, Sampath AM. Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study. World J Gastroenterol. 2012;18:6801–6808.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Dinning PG, Bampton PA, Kennedy ML, et al. Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol. 1999;276:G331–G340.PubMed Dinning PG, Bampton PA, Kennedy ML, et al. Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol. 1999;276:G331–G340.PubMed
12.
Zurück zum Zitat Kajimoto T, Dinning PG, Gibb DB, de Carle DJ, Cook IJ. Neurogenic pathways mediating ascending and descending reflexes at the porcine ileocolonic junction. Neurogastroenterol Motil. 2000;12:125–134.CrossRefPubMed Kajimoto T, Dinning PG, Gibb DB, de Carle DJ, Cook IJ. Neurogenic pathways mediating ascending and descending reflexes at the porcine ileocolonic junction. Neurogastroenterol Motil. 2000;12:125–134.CrossRefPubMed
13.
Zurück zum Zitat Chander Roland B, Ciarleglio M, Clarke J, et al. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Dig Dis Sci. 2014;59:1269–1277. doi:10.1007/s10620-014-3166-7.CrossRef Chander Roland B, Ciarleglio M, Clarke J, et al. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO). Dig Dis Sci. 2014;59:1269–1277. doi:10.​1007/​s10620-014-3166-7.CrossRef
14.
Zurück zum Zitat Chander Roland B, Ciarleglio M, Clarke J, et al. Small intestinal transit time is Prolonged in small intestinal bacterial overgrowth (SIBO). J Clin Gastroenterol. 2015;49:571–576.CrossRef Chander Roland B, Ciarleglio M, Clarke J, et al. Small intestinal transit time is Prolonged in small intestinal bacterial overgrowth (SIBO). J Clin Gastroenterol. 2015;49:571–576.CrossRef
15.
Zurück zum Zitat Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol. 1996;91:1795–1803.PubMed Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol. 1996;91:1795–1803.PubMed
16.
Zurück zum Zitat Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943–959.CrossRefPubMed Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010;24:943–959.CrossRefPubMed
17.
Zurück zum Zitat Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302–309.CrossRefPubMed Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302–309.CrossRefPubMed
18.
Zurück zum Zitat Gasbarrini A, Corazza GR, Gasbarrini G, First Rome H2-Breath Testing Consensus Conference Working Group, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome consensus conference. Aliment Pharmacol Ther. 2009;29:1–49.PubMed Gasbarrini A, Corazza GR, Gasbarrini G, First Rome H2-Breath Testing Consensus Conference Working Group, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome consensus conference. Aliment Pharmacol Ther. 2009;29:1–49.PubMed
19.
Zurück zum Zitat Rao S, Kuo B, McCallum RW, et al. Investigation of colonic and whole gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–544.CrossRefPubMed Rao S, Kuo B, McCallum RW, et al. Investigation of colonic and whole gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol. 2009;7:537–544.CrossRefPubMed
20.
Zurück zum Zitat Tran Khoa, Brun Rita, Kuo Braden. Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice. Therap Adv Gastroenterol. 2012;5:249–260.CrossRefPubMedPubMedCentral Tran Khoa, Brun Rita, Kuo Braden. Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice. Therap Adv Gastroenterol. 2012;5:249–260.CrossRefPubMedPubMedCentral
21.
23.
Zurück zum Zitat Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54–59.CrossRefPubMedPubMedCentral Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54–59.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Shindo K, Fukumura M. Effect of H2-receptor antagonists on bile acid metabolism. J Investig Med. 1995;43:170–177.PubMed Shindo K, Fukumura M. Effect of H2-receptor antagonists on bile acid metabolism. J Investig Med. 1995;43:170–177.PubMed
25.
Zurück zum Zitat Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557–561.CrossRefPubMed Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557–561.CrossRefPubMed
Metadaten
Titel
A Prospective Evaluation of Ileocecal Valve Dysfunction and Intestinal Motility Derangements in Small Intestinal Bacterial Overgrowth
verfasst von
Bani Chander Roland
Gerard E. Mullin
Monica Passi
Xi Zheng
Ahmed Salem
Robert Yolken
Pankaj Jay Pasricha
Publikationsdatum
04.09.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4726-4

Weitere Artikel der Ausgabe 12/2017

Digestive Diseases and Sciences 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.